287 results on '"Chiarelli, Laurent R."'
Search Results
2. Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
3. Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation
4. Synthesis, crystal structure, Hirshfeld surface, computational and antibacterial studies of a 9-phenanthrenecarboxaldehyde-based thiodihydropyrimidine derivative
5. Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent
6. Nitric oxide-releasing compounds for the treatment of lung infections
7. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents
8. The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens
9. PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection
10. Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery
11. Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation
12. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
13. Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
14. Side Chain-modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
15. Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
16. Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
17. The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053
18. Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
19. Crystal Structure, Hirshfeld Surface Analysis, In-Silico and Antimycotic Investigations of Methyl 6-methyl-4-(4-nitrophenyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylate
20. A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro , In Vivo , and against Nonreplicating Cells of Mycobacterium tuberculosis
21. Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens.
22. Antibiotics’ Sustainability: Another Issue in the Fight against Antimicrobial Resistance
23. Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections
24. Monitoring of Inosine Monophosphate Dehydrogenase Activity and Expression during the Early Period of Mycophenolate Mofetil Therapy in De Novo Renal Transplant Patients
25. Editorial: Enzyme targeting for the development of novel antimicrobials.
26. Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents
27. Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
28. Crystal Structure, Hirshfeld Surface Analysis, In-Silico and Antimycotic Investigations of Methyl 6-methyl-4-(4-nitrophenyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylate.
29. Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
30. Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo
31. Molecular basis of pyrimidine 5′-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations
32. Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia
33. A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis
34. Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
35. BEL β-trefoil: A novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms
36. Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.
37. Structure of a lectin with antitumoral properties in king bolete (Boletus edulis) mushrooms
38. 6-Hydroxy-2-methylbenzofuran-4-carboxylic Acid
39. Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
40. Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
41. Antivirulence Compounds: A Future Direction to Overcome Antibiotic Resistance?
42. Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
43. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance
44. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy
45. ThermoFAD, a Thermofluor®-adapted flavin ad hoc detection system for protein folding and ligand binding
46. Functional analysis of pyrimidine 5′-nucleotidase mutants causing nonspherocytic hemolytic anemia
47. Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene
48. Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
49. Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia
50. New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.